Loading clinical trials...
Loading clinical trials...
This study was designed to assess the safety of retrieval of the Bard Recovery® G2® Filter System. The G2 filter is an FDA-cleared device for inferior vena caval interruption in patients with pulmonar...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
C. R. Bard
NCT06183944 · Pulmonary Embolism
NCT06189313 · Pulmonary Embolism, Acute Pulmonary Embolism, and more
NCT06672081 · Pulmonary Embolism Acute Massive
NCT06166329 · Non-severe Pulmonary Embolism, Pulmonary Embolism, and more
NCT06038630 · Interstitial Lung Disease, Chronic Thromboembolic Pulmonary Hypertension, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions